Back to Business

BioMarin to discontinue development of Voxzogo for Noonan syndrome in children

Business September 15, 2026 at 12:52 PM

BioMarin to discontinue development of Voxzogo for Noonan syndrome in children

Investing.com

Read at Investing.com

More Stories

Mark Cuban says he's way more worried about AI backlash than an AI apocalypse

Mark Cuban says he's way more worried about AI backlash than an AI apocalypse

Mark Cuban says public fears about AI could be problematic. Bloomberg/Getty Images Mark Cuban says he's far more worried…

🇺🇸 Business Insider 39m ago

The Largest U.S. Women’s Telehealth Company Has 2 Rules for Its Next Act

The Largest U.S. Women’s Telehealth Company Has 2 Rules for Its Next Act

Keira Krausz plans to expand the telehealth company into fertility, menopause, diagnostics, and a platform designed to s…

🇺🇸 Inc. 42m ago

A $20,000 Legal Invoice Killed His First Company. His New Startup Is Worth $350 Million and Backed by Vinod Khosla

A $20,000 Legal Invoice Killed His First Company. His New Startup Is Worth $350 Million and Backed b…

The legal AI company Spellbook is used by more than 4,500 legal teams across 80 countries.

🇺🇸 Inc. 47m ago

Your world briefing, in your pocket

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play